Page last updated: 2024-09-02

ecteinascidin 743 and Biliary Tract Cancer

ecteinascidin 743 has been researched along with Biliary Tract Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aglietta, M; Bertotti, A; Capussotti, L; Cavalloni, G; Gammaitoni, L; Leone, F; MarchiĆ², S; Medico, E; Peraldo-Neia, C; Sassi, F; Soster, M; Trusolino, L1

Other Studies

1 other study(ies) available for ecteinascidin 743 and Biliary Tract Cancer

ArticleYear
Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models.
    BMC cancer, 2014, Dec-05, Volume: 14

    Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Biliary Tract Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Dioxoles; DNA Repair; Drug Screening Assays, Antitumor; Female; Gene Expression Regulation, Neoplastic; Hedgehog Proteins; Histones; Humans; Interleukin-6; Mice; Mice, Inbred NOD; Neovascularization, Pathologic; Phosphorylation; Tetrahydroisoquinolines; Trabectedin; Tumor Suppressor Protein p53; Wnt Signaling Pathway

2014